"Solanaceous Alkaloids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc. Some act as cholinergic antagonists; most are very toxic; many are used medicinally.
| Descriptor ID |
D012991
|
| MeSH Number(s) |
D03.132.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Solanaceous Alkaloids".
Below are MeSH descriptors whose meaning is more specific than "Solanaceous Alkaloids".
This graph shows the total number of publications written about "Solanaceous Alkaloids" by people in this website by year, and whether "Solanaceous Alkaloids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Solanaceous Alkaloids" by people in Profiles.
-
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19. Front Immunol. 2020; 11:595342.
-
Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer. J Cell Mol Med. 2019 11; 23(11):7749-7761.
-
Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds. Chem Biol Interact. 2019 Aug 01; 308:372-376.
-
Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1. Cell Physiol Biochem. 2017; 43(6):2310-2326.
-
Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm-like pain: A randomized, double-blinded, multicenter Phase III trial. J Dig Dis. 2017 Aug; 18(8):453-460.